RayzeBio
phase trial in first line combination treatment of | RayzeBio
Company
Deck Type
IPO
Sector
Industry
Deck date
September 2023
Slide
26 of 41
Related slides by other companies
MAIA Biotechnology
Investor Presentation
October 2023
thio trial planned a | MAIA Biotechnology
BioAtla
Investor Presentation
January 2024
cab phase mono and study currently underway | BioAtla
MAIA Biotechnology
Investor Presentation
July 2023
thio trial planned | MAIA Biotechnology
MAIA Biotechnology
Investor Presentation
January 2024
thio trial planned | MAIA Biotechnology
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights